Literature DB >> 23107582

Optimization of intraocular lens constant improves refractive outcomes in combined endothelial keratoplasty and cataract surgery.

Gustavo Bonfadini1, John G Ladas, Hamilton Moreira, Mauro Campos, Mario Matthaei, Beatriz Muñoz, Kim Pratzer, Albert S Jun.   

Abstract

PURPOSE: To evaluate the accuracy of intraocular lens (IOL) power calculations with A-constant optimization in Descemet's stripping automated endothelial keratoplasty (DSAEK) combined with cataract extraction and intraocular lens implantation (DSAEK triple procedure).
DESIGN: Retrospective case series. PARTICIPANTS: Thirty eyes of 22 patients with Fuchs' endothelial dystrophy who underwent the DSAEK triple procedure performed by a single surgeon.
METHODS: Prediction errors were calculated retrospectively for consecutive DSAEK triple procedures. These prediction errors then were used to determine an IOL constant for this cohort of patients. The new optimized IOL constant subsequently was compared with the manufacturer's IOL constant, allowing evaluation and quantification of refractive benefits of optimization. MAIN OUTCOMES MEASURES: The error in diopters (D) of the predicted refraction with the manufacturer's and optimized IOL constants.
RESULTS: Optimization of the A constant decreased the mean absolute error (MAE) from 1.09 ± 0.63 D (range, 0.12-2.41 D) to 0.61 ± 0.4 D (range, 0-1.58 D; P = 0.004). Comparing the intended and final postoperative refractions calculated with the original manufacturer's constant and the optimized constant, 20% versus 43% of all eyes were in the less than 0.5-D range and 50% versus 83% of all eyes were in the less than 1.0-D range of the target refraction. Furthermore, optimization decreased the number of eyes that were more than 1.0 D from the target refraction from 50% to 17%.
CONCLUSIONS: Optimization of the IOL constant showed significantly improved accuracy of predicted postoperative refraction compared with the manufacturer's IOL constant, which may help improve the postoperative refractive outcomes in patients undergoing the DSAEK triple procedure.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23107582      PMCID: PMC3816366          DOI: 10.1016/j.ophtha.2012.08.003

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  21 in total

1.  Optimizing intraocular lens power calculations in eyes with axial lengths above 25.0 mm.

Authors:  Li Wang; Mariko Shirayama; Xingxuan Jack Ma; Thomas Kohnen; Douglas D Koch
Journal:  J Cataract Refract Surg       Date:  2011-11       Impact factor: 3.351

2.  Optimized constants for an ultraviolet light-adjustable intraocular lens.

Authors:  Ina Conrad-Hengerer; H Burkhard Dick; Werner W Hütz; Wolfgang Haigis; Fritz H Hengerer
Journal:  J Cataract Refract Surg       Date:  2011-12       Impact factor: 3.351

3.  Graft profile and thickness as a function of cut transition speed in Descemet-stripping automated endothelial keratoplasty.

Authors:  Maninder S Bhogal; Bruce D Allan
Journal:  J Cataract Refract Surg       Date:  2012-04       Impact factor: 3.351

4.  Corneal power measurement with a rotating Scheimpflug imaging system after Descemet-stripping automated endothelial keratoplasty.

Authors:  Pawan Prasher; Orkun Muftuoglu; R Wayne Bowman; H Dwight Cavanagh; James P McCulley; V Vinod Mootha
Journal:  J Cataract Refract Surg       Date:  2010-08       Impact factor: 3.351

5.  Effect on refractive outcomes after cataract surgery of intraocular lens constant personalization using the Haigis formula.

Authors:  Sofia Charalampidou; Lorraine Cassidy; Eugene Ng; James Loughman; John Nolan; Jim Stack; Stephen Beatty
Journal:  J Cataract Refract Surg       Date:  2010-07       Impact factor: 3.351

6.  Intraocular lens formula constant optimization and partial coherence interferometry biometry: Refractive outcomes in 8108 eyes after cataract surgery.

Authors:  Petros Aristodemou; Nathaniel E Knox Cartwright; John M Sparrow; Robert L Johnston
Journal:  J Cataract Refract Surg       Date:  2011-01       Impact factor: 3.351

7.  Intraocular lens power prediction for triple procedures in Fuchs' dystrophy using multiple regression analysis.

Authors:  Anja Viestenz; Berthold Seitz; Achim Langenbucher
Journal:  Acta Ophthalmol Scand       Date:  2005-06

8.  Optimization of biometry for intraocular lens implantation using the Zeiss IOLMaster.

Authors:  Simon N Madge; C H Khong; Meon Lamont; Atul Bansal; Richard J Antcliff
Journal:  Acta Ophthalmol Scand       Date:  2005-08

9.  Improving cataract surgery refractive outcomes.

Authors:  John G Ladas; Walter J Stark
Journal:  Ophthalmology       Date:  2011-09       Impact factor: 12.079

10.  Descemet-stripping automated endothelial keratoplasty.

Authors:  Mark S Gorovoy
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

View more
  4 in total

1.  Using the posterior to anterior corneal curvature radii ratio to minimize the risk of a postoperative hyperopic shift after Descemet membrane endothelial keratoplasty.

Authors:  Raphael Diener; Nicole Eter; Maged Alnawaiseh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-31       Impact factor: 3.117

2.  Personal A-constant in relation to axial length with various intraocular lenses.

Authors:  Mohamed A Eldaly; Khaled A Mansour
Journal:  Indian J Ophthalmol       Date:  2014-07       Impact factor: 1.848

3.  Descemet Stripping Automated Endothelial Keratoplasty in Fuchs' Endothelial Dystrophy versus Pseudophakic Bullous Keratopathy.

Authors:  Mohammad Ali Javadi; Sepehr Feizi; Roya Jafari; Firooz Mirbabaee; Vahid Ownagh
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

4.  Intraocular lens power calculation using standard formulas and ray tracing after DMEK in patients with Fuchs endothelial dystrophy.

Authors:  Maged Alnawaiseh; Lars Zumhagen; André Rosentreter; Nicole Eter
Journal:  BMC Ophthalmol       Date:  2017-08-23       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.